Bull Pharmachem
Bull Pharmachem
Kalbadevi, Mumbai, Maharashtra
GST No. 27AKFPJ6383E1Z2
TrustSEAL Verified
Call 08048419840 88% Response Rate
SEND EMAIL

Anti Cancer Tablets

We are a leading Exporter of abirakast (abiraterone acetate 250mg ), venetoclax 100mg, olaparib 150mg, promacta (eltrombopag 25 mg,50 mg), alunbrig (brigatinib 30mg,90mg,180mg) and xbira (abiraterone acetate 250mg) from Mumbai, India.

Abirakast (Abiraterone Acetate 250mg )

Abirakast (Abiraterone Acetate 250mg )
  • Abirakast (Abiraterone Acetate 250mg )
  • Abirakast (Abiraterone Acetate 250mg )
  • Abirakast (Abiraterone Acetate 250mg )
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size120 Tablet
BrandAbirakast
CompositionAbiraterone Acetate
ManufacturerAprazer Heathcare
TreatmentProstate Cancer
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
FormTablet
Shelf life2 Years
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
Strength250mg

Abirakast (Abiraterone Acetate 250mg ) is a prescription medicine that is used along with prednisone. Abirakast is used to treat men with prostate cancer that has spread to other parts of the body.It is not known if Abirakast is safe and effective in females or children.Before taking Abirakast, tell your healthcare provider about all of your medical conditions, including if you:
Have heart problemsHave liver problemsHave diabetesHave a history of adrenal problemsHave a history of pituitary problemsAre receiving any other treatment for prostate cancerAre pregnant or plan to become pregnant. Abirakast can cause harm to your unborn baby and loss of pregnancy (miscarriage). Females who are or may become pregnant should not handle Abirakast uncoated tablets or other Abirakast tablets if broken, crushed, or damaged without protection, such as glovesHave a partner who is pregnant or may become pregnantMales who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with Abirakast and for 3 weeks after the last dose of AbirakastAre breastfeeding or plan to breastfeed. It is not known if Abirakast passes into your breast milkTell your healthcare provider about all the medicines you take or treatments you receive including prescription and over-the-counter medicines, vitamins, and herbal supplements. Abirakast can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribed Abirakast.
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I take Abirakast?
Take Abirakast and prednisone exactly as your healthcare provider tells youTake your prescribed dose of Abirakast one time a day. Your healthcare provider may change your dose if neededDo not change or stop taking your prescribed dose of Abirakast or prednisone without talking to your healthcare provider firstTake Abirakast on an empty stomach, at least 1 hour before or at least 2 hours after a meal. Do not take Abirakast with food. Taking Abirakast with food may cause more of the medicine to be absorbed by the body than is needed and this may cause side effectsSwallow Abirakast tablets whole. Do not crush or chew tabletsTake Abirakast tablets with waterIf you miss a dose of Abirakast or prednisone, take your prescribed dose the following day. If you miss more than 1 dose, tell your healthcare provider right awayYour healthcare provider will do blood tests to check for side effectsWhat are the possible side effects of Abirakast?
Abirakast may cause serious side effects including:
High blood pressure (hypertension), low blood potassium levels (hypokalemia), fluid retention (edema), and irregular heartbeats can happen during treatment with Abirakast. This can be life-threatening. To decrease the chance of this happening, you must take prednisone with Abirakast exactly as your healthcare provider tells you. Your healthcare provider will check your blood pressure, do blood tests to check your potassium levels, and check for any signs and symptoms of fluid retention every month during treatment with AbirakastTell your healthcare provider if you get any of the following symptoms:DizzinessFast or irregular heartbeatsFeel faint or lightheadedHeadacheConfusionMuscle weaknessPain in your legsSwelling in your legs or feetAdrenal problems may happen if you stop taking prednisone, get an infection, or are under stressSevere liver problems. You may develop changes in liver function blood tests. Your healthcare provider will do blood tests to check your liver before treatment with Abirakast and during treatment with Abirakast. Liver failure may occur, which can lead to death. 
Request
Callback


Additional Information:

  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Venetoclax 100mg

Venetoclax 100mg
  • Venetoclax 100mg
Get Best Quote
Approx. Price: Rs 10 / BottleGet Latest Price

Product Details:

Minimum Order Quantity1 Bottle
Packaging Size120 Tablet
TreatmentBlood cancer
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
FormTablet
Shelf life2 Years

Venetoclax 100mg is a prescription medicine used:
to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who:are 75 years of age or older, orhave other medical conditions that prevent the use of standard chemotherapy.It is not known if Venetoclax  is safe and effective in children.
Important Safety InformationWhat is the most important information I should know about Venetoclax ?Venetoclax  can cause serious side effects, including:
Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. Your healthcare provider will do tests to check your risk of getting TLS before you start taking Venetoclax . You will receive other medicines before starting and during treatment with Venetoclax  to help reduce your risk of TLS. You may also need to receive intravenous (IV) fluids into your vein. Your healthcare provider will do blood tests to check for TLS when you first start treatment and during treatment with Venetoclax . It is important to keep your appointments for blood tests. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with Venetoclax , including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, or muscle or joint pain.
Drink plenty of water during treatment with Venetoclax  to help reduce your risk of getting TLS. Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose, on the day of your first dose of Venetoclax , and each time your dose is increased.
Your healthcare provider may delay, decrease your dose, or stop treatment with Venetoclax  if you have side effects. When restarting Venetoclax  after stopping for 1 week or longer, your healthcare provider may again check for your risk of TLS and change your dose.
Who should not take Venetoclax ?Certain medicines must not be taken when you first start taking Venetoclax  and while your dose is being slowly increased because of the risk of increased TLS.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Venetoclax  and other medicines may affect each other causing serious side effects.Do not start new medicines during treatment with Venetoclax  without first talking with your healthcare provider.Before taking Venetoclax , tell your healthcare provider about all of your medical conditions, including if you:
have kidney or liver problems.have problems with your body salts or electrolytes, such as potassium, phosphorus, or calcium.have a history of high uric acid levels in your blood or gout.are scheduled to receive a vaccine. You should not receive a "live vaccine" before, during, or after treatment with Venetoclax , until your healthcare provider tells you it is okay. If you are not sure about the type of immunization or vaccine, ask your healthcare provider. These vaccines may not be safe or may not work as well during treatment with Venetoclax .are pregnant or plan to become pregnant. Venetoclax  may harm your unborn baby. If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with Venetoclax , and you should use effective birth control during treatment and for at least 30 days after the last dose of Venetoclax . If you become pregnant or think you are pregnant, tell your healthcare provider right away.
Request
Callback


Additional Information:

  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Olaparib 150mg

Olaparib 150mg
  • Olaparib 150mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Minimum Order Quantity1 Box
Drug NameOLAPARIB
Dose/Strength150 Mg
Usage/ApplicationHospital
Grade StandardNA
Packaging TypeStrip
Packaging Size56 tablets
TreatmentBreast Cancer

OLAPARIB is a prescription medicine used to treat adults who have:
advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. OLAPARIB is used alone as maintenance treatment after the cancer has responded to your first treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that OLAPARIB is right for youovarian cancer, fallopian tube cancer, or primary peritoneal cancer, as maintenance treatment, when the cancer has come back. OLAPARIB is used after the cancer has responded to treatment with platinum-based chemotherapyadvanced ovarian cancer with a certain type of abnormal inherited BRCA gene, and have received treatment with 3 or more prior types of chemotherapy medicines. Your healthcare provider will perform a test to make sure that OLAPARIB is right for youa certain type of abnormal inherited BRCA gene, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic). You should have received chemotherapy medicines, either before or after your cancer has spread. If you have hormone receptor (HR)-positive disease, you should have been treated with hormonal therapy. Your healthcare provider will perform a test to make sure that OLAPARIB is right for you.IMPORTANT SAFETY INFORMATION OLAPARIB may cause serious side effects, including:Bone marrow problems called Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Some people who have ovarian cancer or breast cancer and who have received previous treatment with chemotherapy, radiotherapy, or certain other medicines for their cancer have developed MDS or AML during treatment with OLAPARIB. MDS or AML may lead to death. If you develop MDS or AML, your healthcare provider will stop treatment with OLAPARIB.
Symptoms of low blood cell counts are common during treatment with OLAPARIB, but can be a sign of serious bone marrow problems, including MDS or AML. Symptoms may include weakness, weight loss, fever, frequent infections, blood in urine or stool, shortness of breath, feeling very tired, bruising or bleeding more easily.
Your healthcare provider will do blood tests to check your blood cell counts:before treatment with OLAPARIBevery month during treatment with OLAPARIBweekly if you have low blood cell counts that last a long time. Your healthcare provider may stop treatment with OLAPARIB until your blood cell counts improveLung problems (pneumonitis). Tell your healthcare provider if you have any new or worsening symptoms of lung problems, including shortness of breath, fever, cough, or wheezing. Your healthcare provider may do a chest x-ray if you have any of these symptoms. Your healthcare provider may temporarily or completely stop treatment if you develop pneumonitis. Pneumonitis may lead to death.
Before taking OLAPARIB, tell your healthcare provider about all of your medical conditions, including if you:have lung or breathing problemshave kidney problemsare pregnant, become pregnant, or plan to become pregnant. OLAPARIB can harm your unborn baby and may cause loss of pregnancy (miscarriage)If you are able to become pregnant, your healthcare provider may do a pregnancy test before you start treatment with OLAPARIBFemales who are able to become pregnant should use effective birth control (contraception) during treatment with OLAPARIB and for 6 months after the last dose of OLAPARIB. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant or think you might be pregnant following treatment with OLAPARIBMales with female partners who are pregnant or able to become pregnant should use effective birth control (contraception) during treatment with OLAPARIB and for 3 months after the last dose of OLAPARIB
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Promacta (Eltrombopag 25 Mg,50 Mg)

Promacta (Eltrombopag 25 Mg,50 Mg)
  • Promacta (Eltrombopag 25 Mg,50 Mg)
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size30 Tablets
BrandPromacta
CompositionEltrombopag
ManufacturerNovartis India Ltd
TreatmentAplastic anemia
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
FormTablet
Shelf life2 Years
Country of OriginMade in India

Promacta (Eltrombopag 25mg,50mg) Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.  Promacta 50mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.  Take it in the exact dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.  The common side effects include nausea, vomiting, diarrhea, upper respiratory tract infection, and urinary tract infection. Let your doctor know if any of these side effects bother you. They may be able able to suggest ways to reduce or treat the symptoms.  Before you take this medicine, inform your doctor if you have any preexisting medical conditions. Let your doctor also know about all the other medicines you are taking. Dose adjustments may be required in patients with liver diseases, inform your doctor. USES OF REVOLADE TABLET Low platelet count due to ITP or HCV infection Treatment of Severe Aplastic Anemia BENEFITS OF REVOLADE TABLET In Low platelet count due to ITP or HCV infection Promacta 50mg Tablet is used to increase the number of platelets (cells that help the blood clot) to decrease the risk of bleeding in adults and children 1 year of age and older who have chronic idiopathic thrombocytopenic purpura (ITP, an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood). It is used in patients who have not benefited or cannot be treated with other treatments, including medications or surgery to remove the spleen. Promacta 50mg Tablet is also used to increase the number of platelets in people who have hepatitis C (a viral infection that may damage the liver). It is usually given along with other medicines. Show More SIDE EFFECTS OF REVOLADE TABLET Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Promacta Nausea Diarrhea Upper respiratory tract infection Vomiting Increased liver enzymes Muscle pain Urinary tract infection HOW TO USE REVOLADE TABLET Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Promacta 50mg Tablet is to be taken empty stomach. HOW REVOLADE TABLET WORKS Promacta 50mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding. SAFETY ADVICE warnings Alcohol CONSULT YOUR DOCTOR It is not known whether it is safe to consume alcohol with Promacta 50mg Tablet. Please consult your doctor. warnings Pregnancy CONSULT YOUR DOCTOR Promacta 50mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. warnings Breastfeeding CONSULT YOUR DOCTOR Promacta 50mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. warnings Driving UNSAFE Promacta 50mg Tablet may cause side effects which could affect your ability to drive.
 
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Alunbrig (Brigatinib 30mg,90mg,180mg)

Alunbrig (Brigatinib 30mg,90mg,180mg)
  • Alunbrig (Brigatinib 30mg,90mg,180mg)
  • Alunbrig (Brigatinib 30mg,90mg,180mg)
  • Alunbrig (Brigatinib 30mg,90mg,180mg)
Ask For Price
Product Price :Get Latest Price

Product Details:

Minimum Order Quantity1 Bottle
Strength30mg,90mg,180mg
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
TreatmentLung Cancer
DISCLAIMERTrademark shown are property of their respective owners and we do not lay any claim on them. Parall
Pack Size180 Tablets
pack TypeBottle
Minimum Order Quantity180 Tablets

Alunbrig (Brigatinib 30mg,90mg,180mg) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, and that has spread to other parts of your body It is not known if Alunbrig is safe and effective in children. What are the possible side effects of Alunbrig? Alunbrig may cause serious side effects, including: The most common side effects of Alunbrig include: diarrhea fatigue nausea rash cough muscle pain headache high blood pressure vomiting difficulty breathing Alunbrig may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility. These are not all of the possible side effects of Alunbrig. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. DESCRIPTION Brigatinib is a kinase inhibitor. The chemical name for brigatinib is 5-chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine. The molecular formula is C29H39ClN7O2P which corresponds to a formula weight of 584.10 g/mol. Brigatinib has no chiral centers. The chemical structure is shown below: ALUNBRIG™ (brigatinib) Structural Formula Illustration Brigatinib is an off-white to beige/tan solid. The pKas were determined to be: 1.73 ± 0.02 (base), 3.65 ± 0.01 (base), 4.72 ± 0.01 (base), and 8.04 ± 0.01 (base). ALUNBRIG is supplied for oral use as film-coated tablets containing 30 mg or 90 mg of brigatinib and the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (Type A), magnesium stearate, and hydrophobic colloidal silica. The tablet coating consists of talc, polyethylene glycol, polyvinyl alcohol, and titanium dioxide. Indications & Dosage INDICATIONS ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test [see DOSAGE AND ADMINISTRATION]. DOSAGE AND ADMINISTRATION Patient Selection Select patients for the treatment of metastatic NSCLC with ALUNBRIG based on the presence of ALK positivity in tumor specimens [see Clinical Studies]. Recommended Dosage The recommended dosage for ALUNBRIG is: 90 mg orally once daily for the first 7 days; then increase the dose to 180 mg orally once daily. Administer ALUNBRIG until disease progression or unacceptable toxicity. If ALUNBRIG is interrupted for 14 days or longer for reasons other than adverse reactions, resume treatment at 90 mg once daily for 7 days before increasing to the previously tolerated dose. ALUNBRIG may be taken with or without food. Instruct patients to swallow tablets whole. Do not crush or chew tablets.
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Xbira (Abiraterone Acetate 250mg)

Xbira (Abiraterone Acetate 250mg)
  • Xbira (Abiraterone Acetate 250mg)
  • Xbira (Abiraterone Acetate 250mg)
  • Xbira (Abiraterone Acetate 250mg)
  • Xbira (Abiraterone Acetate 250mg)
  • Xbira (Abiraterone Acetate 250mg)
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size120 Tablet
BrandXbira
CompositionAbiraterone Acetate
ManufacturerCipla
TreatmentProstate Cancer
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
Shelf life2 Years
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
Strength250mg

Xbira (Abiraterone Acetate 250mg) is a prescription medicine that is used along with prednisone. Xbira is used to treat men with prostate cancer that has spread to other parts of the body.It is not known if Xbira is safe and effective in females or children.Before taking Xbira, tell your healthcare provider about all of your medical conditions, including if you:
Have heart problemsHave liver problemsHave diabetesHave a history of adrenal problemsHave a history of pituitary problemsAre receiving any other treatment for prostate cancerAre pregnant or plan to become pregnant. Xbira can cause harm to your unborn baby and loss of pregnancy (miscarriage). Females who are or may become pregnant should not handle Xbira uncoated tablets or other Xbira tablets if broken, crushed, or damaged without protection, such as glovesHave a partner who is pregnant or may become pregnantMales who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with Xbira and for 3 weeks after the last dose of XbiraAre breastfeeding or plan to breastfeed. It is not known if Xbira passes into your breast milkTell your healthcare provider about all the medicines you take or treatments you receive including prescription and over-the-counter medicines, vitamins, and herbal supplements. Xbira can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribed Xbira.
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I take Xbira?
Take Xbira and prednisone exactly as your healthcare provider tells youTake your prescribed dose of Xbira one time a day. Your healthcare provider may change your dose if neededDo not change or stop taking your prescribed dose of Xbira or prednisone without talking to your healthcare provider firstTake Xbira on an empty stomach, at least 1 hour before or at least 2 hours after a meal. Do not take Xbira with food. Taking Xbira with food may cause more of the medicine to be absorbed by the body than is needed and this may cause side effectsSwallow Xbira tablets whole. Do not crush or chew tabletsTake Xbira tablets with waterIf you miss a dose of Xbira or prednisone, take your prescribed dose the following day. If you miss more than 1 dose, tell your healthcare provider right awayYour healthcare provider will do blood tests to check for side effectsWhat are the possible side effects of Xbira?
Xbira may cause serious side effects including:
High blood pressure (hypertension), low blood potassium levels (hypokalemia), fluid retention (edema), and irregular heartbeats can happen during treatment with Xbira. This can be life-threatening. To decrease the chance of this happening, you must take prednisone with Xbira exactly as your healthcare provider tells you. Your healthcare provider will check your blood pressure, do blood tests to check your potassium levels, and check for any signs and symptoms of fluid retention every month during treatment with XbiraTell your healthcare provider if you get any of the following symptoms:DizzinessFast or irregular heartbeatsFeel faint or lightheadedHeadacheConfusionMuscle weaknessPain in your legsSwelling in your legs or feetAdrenal problems may happen if you stop taking prednisone, get an infection, or are under stressSevere liver problems. You may develop changes in liver function blood tests. Your healthcare provider will do blood tests to check your liver before treatment with Xbira and during treatment with Xbira. Liver failure may occur, which can lead to death. 
Request
Callback


Additional Information:

  • Delivery Time: immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Abirapro (Abiraterone Acetate 250mg)

Abirapro (Abiraterone Acetate 250mg)
  • Abirapro (Abiraterone Acetate 250mg)
  • Abirapro (Abiraterone Acetate 250mg)
  • Abirapro (Abiraterone Acetate 250mg)
  • Abirapro (Abiraterone Acetate 250mg)
Ask For Price
Product Price :Get Latest Price

Product Details:

Packaging Size120 Tablet
BrandAbirapro
CompositionAbiraterone Acetate
ManufacturerGlenmark
TreatmentProstate Cancer
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
FormTablet
Shelf life2 Years
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
Strength250mg

Abirapro (Abiraterone Acetate 250mg) is a prescription medicine that is used along with prednisone. Abirapro is used to treat men with prostate cancer that has spread to other parts of the body.It is not known if Abirapro is safe and effective in females or children.Before taking Abirapro, tell your healthcare provider about all of your medical conditions, including if you:
Have heart problemsHave liver problemsHave diabetesHave a history of adrenal problemsHave a history of pituitary problemsAre receiving any other treatment for prostate cancerAre pregnant or plan to become pregnant. Abirapro can cause harm to your unborn baby and loss of pregnancy (miscarriage). Females who are or may become pregnant should not handle Abirapro uncoated tablets or other Abirapro tablets if broken, crushed, or damaged without protection, such as glovesHave a partner who is pregnant or may become pregnantMales who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with Abirapro and for 3 weeks after the last dose of AbiraproAre breastfeeding or plan to breastfeed. It is not known if Abirapro passes into your breast milkTell your healthcare provider about all the medicines you take or treatments you receive including prescription and over-the-counter medicines, vitamins, and herbal supplements. Abirapro can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribed Abirapro.
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I take Abirapro?
Take Abirapro and prednisone exactly as your healthcare provider tells youTake your prescribed dose of Abirapro one time a day. Your healthcare provider may change your dose if neededDo not change or stop taking your prescribed dose of Abirapro or prednisone without talking to your healthcare provider firstTake Abirapro on an empty stomach, at least 1 hour before or at least 2 hours after a meal. Do not take Abirapro with food. Taking Abirapro with food may cause more of the medicine to be absorbed by the body than is needed and this may cause side effectsSwallow Abirapro tablets whole. Do not crush or chew tabletsTake Abirapro tablets with waterIf you miss a dose of Abirapro or prednisone, take your prescribed dose the following day. If you miss more than 1 dose, tell your healthcare provider right awayYour healthcare provider will do blood tests to check for side effectsWhat are the possible side effects of Abirapro?
Abirapro may cause serious side effects including:
High blood pressure (hypertension), low blood potassium levels (hypokalemia), fluid retention (edema), and irregular heartbeats can happen during treatment with Abirapro. This can be life-threatening. To decrease the chance of this happening, you must take prednisone with Abirapro exactly as your healthcare provider tells you. Your healthcare provider will check your blood pressure, do blood tests to check your potassium levels, and check for any signs and symptoms of fluid retention every month during treatment with AbiraproTell your healthcare provider if you get any of the following symptoms:DizzinessFast or irregular heartbeatsFeel faint or lightheadedHeadacheConfusionMuscle weaknessPain in your legsSwelling in your legs or feetAdrenal problems may happen if you stop taking prednisone, get an infection, or are under stressSevere liver problems. You may develop changes in liver function blood tests. 

Request
Callback


Additional Information:

  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Abiraterone Acetate 250MG

Abiraterone Acetate 250MG
  • Abiraterone Acetate 250MG
  • Abiraterone Acetate 250MG
Ask For Price
Product Price :Get Latest Price
Abiraterone Acetate 250mg is a prescription medicine that is used along with prednisone. Abiraterone Acetate is used to treat men with prostate cancer that has spread to other parts of the body.It is not known if Abiraterone Acetate is safe and effective in females or children.Before takingAbiraterone Acetate , tell your healthcare provider about all of your medical conditions, including if you:
Have heart problemsHave liver problemsHave diabetesHave a history of adrenal problemsHave a history of pituitary problemsAre receiving any other treatment for prostate cancerAre pregnant or plan to become pregnant. Abiraterone Acetate can cause harm to your unborn baby and loss of pregnancy (miscarriage). Females who are or may become pregnant should not handle Abiraterone Acetate uncoated tablets or other Abiraterone Acetate tablets if broken, crushed, or damaged without protection, such as glovesHave a partner who is pregnant or may become pregnantMales who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with Abiraterone Acetate and for 3 weeks after the last dose ofAbiraterone Acetate Are breastfeeding or plan to breastfeed. It is not known if Abiraterone Acetate passes into your breast milkTell your healthcare provider about all the medicines you take or treatments you receive including prescription and over-the-counter medicines, vitamins, and herbal supplements. Abiraterone Acetate can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribedAbiraterone Acetate .
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I takeAbiraterone Acetate ?
Take Abiraterone Acetate and prednisone exactly as your healthcare provider tells youTake your prescribed dose of Abiraterone Acetate one time a day. Your healthcare provider may change your dose if neededDo not change or stop taking your prescribed dose of Abiraterone Acetate or prednisone without talking to your healthcare provider firstTake Abiraterone Acetate on an empty stomach, at least 1 hour before or at least 2 hours after a meal. Do not take Abiraterone Acetate with food. Taking Abiraterone Acetate with food may cause more of the medicine to be absorbed by the body than is needed and this may cause side effectsSwallow Abiraterone Acetate tablets whole. Do not crush or chew tabletsTake Abiraterone Acetate tablets with waterIf you miss a dose of Abiraterone Acetate or prednisone, take your prescribed dose the following day. If you miss more than 1 dose, tell your healthcare provider right awayYour healthcare provider will do blood tests to check for side effectsWhat are the possible side effects ofAbiraterone Acetate ?
Abiraterone Acetate may cause serious side effects including:
High blood pressure (hypertension), low blood potassium levels (hypokalemia), fluid retention (edema), and irregular heartbeats can happen during treatment withAbiraterone Acetate . This can be life-threatening. To decrease the chance of this happening, you must take prednisone with Abiraterone Acetate exactly as your healthcare provider tells you. Your healthcare provider will check your blood pressure, do blood tests to check your potassium levels, and check for any signs and symptoms of fluid retention every month during treatment withAbiraterone Acetate Tell your healthcare provider if you get any of the following symptoms:DizzinessFast or irregular heartbeatsFeel faint or lightheadedHeadacheConfusionMuscle weaknessPain in your legsSwelling in your legs or feetAdrenal problems may happen if you stop taking prednisone, get an infection, or are under stressSevere liver problems.

Request
Callback


Additional Information:

  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Brigatinib 30mg,90mg,180mg

Brigatinib 30mg,90mg,180mg
  • Brigatinib 30mg,90mg,180mg
  • Brigatinib 30mg,90mg,180mg
  • Brigatinib 30mg,90mg,180mg
Ask For Price
Product Price :Get Latest Price

Product Details:

Minimum Order Quantity1 Box
Strength30mg,90mg,180mg
Pack Size180 Tablets
pack TypeBottle
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
DosageTake Brigatinib Tablet only as per the dose and duration suggested by your doctor.
TreatmentLung Cancer
DISCLAIMERTrademark shown are property of their respective owners and we do not lay any claim on them. Parall

Brigatinib 30mg,90mg,180mg is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):
that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, andthat has spread to other parts of your bodyIt is not known if Brigatinib is safe and effective in children.
What are the possible side effects of Alunbrig?
Brigatinib may cause serious side effects, including:The most common side effects of Brigatinib include:
diarrheafatiguenausearashcoughmuscle painheadachehigh blood pressurevomitingdifficulty breathingBrigatinib may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.
These are not all of the possible side effects of Alunbrig.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
DESCRIPTIONBrigatinib is a kinase inhibitor. The chemical name for brigatinib is 5-chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine. The molecular formula is C29H39ClN7O2P which corresponds to a formula weight of 584.10 g/mol. Brigatinib has no chiral centers. The chemical structure is shown below:
ALUNBRIG™ (brigatinib) Structural Formula IllustrationBrigatinib is an off-white to beige/tan solid. The pKas were determined to be: 1.73 ± 0.02 (base), 3.65 ± 0.01 (base), 4.72 ± 0.01 (base), and 8.04 ± 0.01 (base).
ALUNBRIG is supplied for oral use as film-coated tablets containing 30 mg or 90 mg of brigatinib and the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (Type A), magnesium stearate, and hydrophobic colloidal silica. The tablet coating consists of talc, polyethylene glycol, polyvinyl alcohol, and titanium dioxide.
Indications & DosageINDICATIONSALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test [see DOSAGE AND ADMINISTRATION].
DOSAGE AND ADMINISTRATIONPatient SelectionSelect patients for the treatment of metastatic NSCLC with ALUNBRIG based on the presence of ALK positivity in tumor specimens [see Clinical Studies].
Recommended DosageThe recommended dosage for ALUNBRIG is:
90 mg orally once daily for the first 7 days; then increase the dose to 180 mg orally once daily.Administer ALUNBRIG until disease progression or unacceptable toxicity.
If ALUNBRIG is interrupted for 14 days or longer for reasons other than adverse reactions, resume treatment at 90 mg once daily for 7 days before increasing to the previously tolerated dose.
ALUNBRIG may be taken with or without food. Instruct patients to swallow tablets whole. Do not crush or chew tablets.
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
Yes! I am Interested

Tofajak Tofacitinib 5 mg Tablets

Tofajak Tofacitinib 5 mg Tablets
  • Tofajak Tofacitinib 5 mg Tablets
  • Tofajak Tofacitinib 5 mg Tablets
  • Tofajak Tofacitinib 5 mg Tablets
Ask For Price
Product Price :Get Latest Price

Product Details:

Strength / Dose5 mg
BrandTofajak
Packaging Size60 Tablets
CompositionTofacitinib
Packaging TypeBottle
TreatmentRheumatoid Arthritis
Prescription/Non prescriptionPrescription
ManufacturerCipla
Tablets in a Bottle60
Also givesThird Party Manufacturing
Shelf life2 Years
Country of OriginMade in India

Tofajak (Tofacitinib 5mg) can lower the ability of your immune system to fight infections. Do not start taking Tofajak  if you have any kind of infection unless your healthcare provider tells you it is okay. Serious Infections have happened in people taking Tofajak . These serious infections include tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting and during treatment with Tofajak .
Before and after starting Tofajak , tell your doctor if you have an infection or symptoms of an infection, including:
Fever, sweating, or chillsCoughBlood in phlegmWarm, red, or painful skin or sores on your bodyBurning when you urinateUrinating more often than normalMuscle achesShortness of breathWeight lossDiarrhea or stomach painFeeling very tiredIncreased risk of death in people 50 years of age and older with rheumatoid arthritis who have at least 1 heart disease (cardiovascular) risk factor and who are taking a higher than recommended dose of Tofajak /Tofajak  XR. The recommended dose in patients with rheumatoid arthritis and psoriatic arthritis is Tofajak  5 mg twice daily or Tofajak  XR 11 mg one time each day.
Cancer. Tofajak  may increase your risk of certain cancers by changing the way your immune system works. Lymphoma and other cancers, including skin cancers, can happen. Tell your healthcare provider if you have ever had any type of cancer.
Higher dose.  People taking the higher dose of Tofajak  (10 mg twice daily) or Tofajak  XR (22 mg one time each day) have a higher risk of serious infections, shingles, or skin cancers.
Immune System Problem. Some people who have taken Tofajak  with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control (Epstein Barr Virus–associated post-transplant lymphoproliferative disorder).
Blood clots in the lungs (pulmonary embolism, PE), veins of the legs (deep vein thrombosis, DVT) and arteries (arterial thrombosis) have happened more often in patients with rheumatoid arthritis who are 50 years of age and older and with at least 1 heart disease (cardiovascular) risk factor taking a higher than recommended dose of Tofajak /Tofajak  XR. Blood clots in the lungs have also happened in patients with ulcerative colitis. Some people have died from these blood clots.
• Stop taking Tofajak  and tell your healthcare provider right away if you have any signs and symptoms of blood clots such as sudden shortness of breath, difficulty breathing, chest pain, swelling of a leg or arm, leg pain or tenderness, or red or discolored skin in the leg or arm.
Tears (perforation) in the stomach or intestines. Tell your healthcare provider if you have had diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines. Some people taking Tofajak  can get tears in their stomach or intestine. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate. Tell your healthcare provider right away if you have fever, stomach-area pain that does not go away, and a change in your bowel habits.
Serious allergic reactions can occur. Stop using Tofajak  and call your healthcare provider right away if you have swelling of your lips, tongue, throat, or get hives.














Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Zytiga (Abiraterone Acetate 250mg )

Zytiga (Abiraterone Acetate 250mg )
  • Zytiga (Abiraterone Acetate 250mg )
  • Zytiga (Abiraterone Acetate 250mg )
  • Zytiga (Abiraterone Acetate 250mg )
Ask For Price
Product Price :Get Latest Price

Product Details:

Minimum Order Quantity1 Piece
Packaging Size120 Tablet
BrandZytiga
CompositionAbiraterone Acetate
ManufacturerJohnson & Johnson
TreatmentProstate Cancer
Prescription/Non prescriptionPrescription
Deals inThird Party Manufacturing
FormTablet
Shelf life2 Years
Storage20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)

ZYTIGA (abiraterone acetate 250mg) is a prescription medicine that is used along with prednisone. ZYTIGA is used to treat men with prostate cancer that has spread to other parts of the body.It is not known if ZYTIGA is safe and effective in females or children.Before taking ZYTIGA, tell your healthcare provider about all of your medical conditions, including if you:
Have heart problemsHave liver problemsHave diabetesHave a history of adrenal problemsHave a history of pituitary problemsAre receiving any other treatment for prostate cancerAre pregnant or plan to become pregnant. ZYTIGA can cause harm to your unborn baby and loss of pregnancy (miscarriage). Females who are or may become pregnant should not handle ZYTIGA uncoated tablets or other ZYTIGA tablets if broken, crushed, or damaged without protection, such as glovesHave a partner who is pregnant or may become pregnantMales who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ZYTIGA and for 3 weeks after the last dose of ZYTIGAAre breastfeeding or plan to breastfeed. It is not known if ZYTIGA passes into your breast milkTell your healthcare provider about all the medicines you take or treatments you receive including prescription and over-the-counter medicines, vitamins, and herbal supplements. ZYTIGA can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribed ZYTIGA.
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I take ZYTIGA?
Take ZYTIGA and prednisone exactly as your healthcare provider tells youTake your prescribed dose of ZYTIGA one time a day. Your healthcare provider may change your dose if neededDo not change or stop taking your prescribed dose of ZYTIGA or prednisone without talking to your healthcare provider firstTake ZYTIGA on an empty stomach, at least 1 hour before or at least 2 hours after a meal. Do not take ZYTIGA with food. Taking ZYTIGA with food may cause more of the medicine to be absorbed by the body than is needed and this may cause side effectsSwallow ZYTIGA tablets whole. Do not crush or chew tabletsTake ZYTIGA tablets with waterIf you miss a dose of ZYTIGA or prednisone, take your prescribed dose the following day. If you miss more than 1 dose, tell your healthcare provider right awayYour healthcare provider will do blood tests to check for side effectsWhat are the possible side effects of ZYTIGA?
ZYTIGA may cause serious side effects including:
High blood pressure (hypertension), low blood potassium levels (hypokalemia), fluid retention (edema), and irregular heartbeats can happen during treatment with ZYTIGA. This can be life-threatening. To decrease the chance of this happening, you must take prednisone with ZYTIGA exactly as your healthcare provider tells you. Your healthcare provider will check your blood pressure, do blood tests to check your potassium levels, and check for any signs and symptoms of fluid retention every month during treatment with ZYTIGATell your healthcare provider if you get any of the following symptoms:DizzinessFast or irregular heartbeatsFeel faint or lightheadedHeadacheConfusionMuscle weaknessPain in your legsSwelling in your legs or feetAdrenal problems may happen if you stop taking prednisone, get an infection, or are under stressSevere liver problems. You may develop changes in liver function blood tests. Your healthcare provider will do blood tests to check your liver before treatment with ZYTIGA and during treatment with ZYTIGA.
Request
Callback


Additional Information:

  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO’s TRIPS agreement to which India is a Signatory. On this page we have made an “Honest Reference” of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested
X

Explore More Product

View All Product


Reach Us
Rakshit Jain (Sales & Marketing Manager)
Bull Pharmachem
No. 64C, Dhan Sadan Co Operative Housing Society, 2nd Floor
Kalbadevi, Mumbai - 400002, Maharashtra, India


Call Us


Send E-mail